MAX Tussin Cough and Chest Congestion DM

NDC 71399-0025 · Akron Pharma Inc.

Generic nameDextromethorphan HBr, Guaifenesin

Dosage formLIQUID

RouteORAL

Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN

Strength20; 200 mg/10mL; mg/10mL

Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]

Marketing categoryOTC MONOGRAPH DRUG

Packages

71399-0025-4 — 1 BOTTLE, PLASTIC in 1 PACKAGE (71399-0025-4) / 118 mL in 1 BOTTLE, PLASTIC

71399-0025-6 — 473 mL in 1 BOTTLE, PLASTIC (71399-0025-6)

71399-0025-8 — 1 BOTTLE, PLASTIC in 1 PACKAGE (71399-0025-8) / 236 mL in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71205-624 — Codeine Phosphate and Guaifenesin, 71205-654 — Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution, 71309-461 — GUAIFENESIN, 71335-1035 — Guaifenesin, 71335-1928 — Guaifenesin and Dextromethorphan HBr, 71335-2032 — Guaifenesin, 71335-2216 — Dextromethorphan Hydrobromide / Guaifenesin, 71335-2642 — Guaifenesin, 71335-9616 — Guaifenesin, 71399-0024 — Guaifenesin, 71399-0026 — Dextromethorphan HBr, Guaifenesin, 71399-0054 — Guaifenesin, 71598-100 — Dextromethorphan Hbr, 71598-102 — Dextromethorphan HBr, 71598-152 — DEXTROMETHORPHAN HYDROBROMIDE, 71598-200 — DEXTROMETHORPHAN HYDROBROMIDE, 71610-098 — Guaifenesin 200 mg, 71610-434 — Guaifenesin, 71610-499 — Guaifenesin, 71679-101 — acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels